1. Lu, H.P. (2022) Clinical Efficacy and Safety of Anlotinib Combined with Etoposide in Second-Line Treatment of Small Cell Lung Cancer. Modern Health Maintenance, No. 20, 1712-1714.
2. Small cell lung cancer: Subtypes and therapeutic implications
3. Liguori, N.R., Sanchez, S.U.A., Zhang, L.Q., et al. (2022) Preclinical Studies with ONC201/TIC10 and Lurbinectedin as a Novel Combination Therapy in Small Cell Lung Cancer (SCLC). American Journal of Cancer Research, 12, 729-743.
4. Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC
5. A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC)